Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 75 entries
Sorted by: Best Match Show Resources per page
Surgical management of hepatocellular carcinoma after Fontan procedure.

Journal of gastrointestinal oncology

Kwon S, Scovel L, Yeh M, Dorsey D, Dembo G, Krieger EV, Bakthavatsalam R, Park JO, Riggle KM, Riehle KJ, Yeung RS.
PMID: 26029468
J Gastrointest Oncol. 2015 Jun;6(3):E55-60. doi: 10.3978/j.issn.2078-6891.2015.009.

The Fontan operation has successfully prolonged the lives of patients born with single-ventricle physiology. A long-term consequence of post-Fontan elevation in systemic venous pressure and low cardiac output is chronic liver inflammation and cirrhosis, which lead to an increased...

Cite
Kwon S, Scovel L, Yeh M, et al. Surgical management of hepatocellular carcinoma after Fontan procedure. J Gastrointest Oncol. 2015;6(3):E55-60doi: 10.3978/j.issn.2078-6891.2015.009.
Kwon, S., Scovel, L., Yeh, M., Dorsey, D., Dembo, G., Krieger, E. V., Bakthavatsalam, R., Park, J. O., Riggle, K. M., Riehle, K. J., & Yeung, R. S. (2015). Surgical management of hepatocellular carcinoma after Fontan procedure. Journal of gastrointestinal oncology, 6(3), E55-60. https://doi.org/10.3978/j.issn.2078-6891.2015.009
Kwon, Steve, et al. "Surgical management of hepatocellular carcinoma after Fontan procedure." Journal of gastrointestinal oncology vol. 6,3 (2015): E55-60. doi: https://doi.org/10.3978/j.issn.2078-6891.2015.009
Kwon S, Scovel L, Yeh M, Dorsey D, Dembo G, Krieger EV, Bakthavatsalam R, Park JO, Riggle KM, Riehle KJ, Yeung RS. Surgical management of hepatocellular carcinoma after Fontan procedure. J Gastrointest Oncol. 2015 Jun;6(3):E55-60. doi: 10.3978/j.issn.2078-6891.2015.009. PMID: 26029468; PMCID: PMC4397258.
Copy Download .nbib Format: NLM
de Sitter Vacua from an Anomalous Gauge Symmetry.

Physical review letters

Buchmuller W, Dierigl M, Ruehle F, Schweizer J.
PMID: 27314713
Phys Rev Lett. 2016 Jun 03;116(22):221303. doi: 10.1103/PhysRevLett.116.221303. Epub 2016 Jun 03.

We find a new class of metastable de Sitter solutions in compactifications of six-dimensional supergravity motivated by type IIB or heterotic string vacua. Two Fayet-Iliopoulos terms of a local U(1) symmetry are generated by magnetic flux and by the...

Cite
Buchmuller W, Dierigl M, Ruehle F, et al. de Sitter Vacua from an Anomalous Gauge Symmetry. Phys Rev Lett. 2016;116(22):221303doi: 10.1103/PhysRevLett.116.221303.
Buchmuller, W., Dierigl, M., Ruehle, F., & Schweizer, J. (2016). de Sitter Vacua from an Anomalous Gauge Symmetry. Physical review letters, 116(22), 221303. https://doi.org/10.1103/PhysRevLett.116.221303
Buchmuller, Wilfried, et al. "de Sitter Vacua from an Anomalous Gauge Symmetry." Physical review letters vol. 116,22 (2016): 221303. doi: https://doi.org/10.1103/PhysRevLett.116.221303
Buchmuller W, Dierigl M, Ruehle F, Schweizer J. de Sitter Vacua from an Anomalous Gauge Symmetry. Phys Rev Lett. 2016 Jun 03;116(22):221303. doi: 10.1103/PhysRevLett.116.221303. Epub 2016 Jun 03. PMID: 27314713.
Copy Download .nbib Format: NLM
Electrochemical and spectroscopic characterization of the novel charge-transfer ground state in diimine complexes of ytterbocene.

Inorganic chemistry

Da Re RE, Kuehl CJ, Brown MG, Rocha RC, Bauer ED, John KD, Morris DE, Shreve AP, Sarrao JL.
PMID: 12950203
Inorg Chem. 2003 Sep 08;42(18):5551-9. doi: 10.1021/ic030069i.

The novel charge-transfer ground state found in alpha,alpha'-diimine adducts of ytterbocene (C(5)Me(5))(2)Yb(L) [L = 2,2'-bipyridine (bpy) and 1,10-phenanthroline (phen)] in which an electron is spontaneously transferred from the f(14) metal center into the lowest unoccupied (pi*) molecular orbital (LUMO)...

Cite
Da Re RE, Kuehl CJ, Brown MG, et al. Electrochemical and spectroscopic characterization of the novel charge-transfer ground state in diimine complexes of ytterbocene. Inorg Chem. 2003;42(18):5551-9doi: 10.1021/ic030069i.
Da Re, R. E., Kuehl, C. J., Brown, M. G., Rocha, R. C., Bauer, E. D., John, K. D., Morris, D. E., Shreve, A. P., & Sarrao, J. L. (2003). Electrochemical and spectroscopic characterization of the novel charge-transfer ground state in diimine complexes of ytterbocene. Inorganic chemistry, 42(18), 5551-9. https://doi.org/10.1021/ic030069i
Da Re, Ryan E, et al. "Electrochemical and spectroscopic characterization of the novel charge-transfer ground state in diimine complexes of ytterbocene." Inorganic chemistry vol. 42,18 (2003): 5551-9. doi: https://doi.org/10.1021/ic030069i
Da Re RE, Kuehl CJ, Brown MG, Rocha RC, Bauer ED, John KD, Morris DE, Shreve AP, Sarrao JL. Electrochemical and spectroscopic characterization of the novel charge-transfer ground state in diimine complexes of ytterbocene. Inorg Chem. 2003 Sep 08;42(18):5551-9. doi: 10.1021/ic030069i. PMID: 12950203.
Copy Download .nbib Format: NLM
Toward new paradigms in mixed-valency: ytterbocene-terpyridine charge-transfer complexes.

Chemical communications (Cambridge, England)

Kuehl CJ, Da Re RE, Scott BL, Morris DE, John KD.
PMID: 14518902
Chem Commun (Camb). 2003 Sep 21;(18):2336-7. doi: 10.1039/b306484k.

(C5Me5)2Yb x OEt2 reacts with terpyridine and tetrapyridinylpyrazine to afford new mixed-valent systems.

Cite
Kuehl CJ, Da Re RE, Scott BL, et al. Toward new paradigms in mixed-valency: ytterbocene-terpyridine charge-transfer complexes. Chem Commun (Camb). 2003;(18):2336-7doi: 10.1039/b306484k.
Kuehl, C. J., Da Re, R. E., Scott, B. L., Morris, D. E., & John, K. D. (2003). Toward new paradigms in mixed-valency: ytterbocene-terpyridine charge-transfer complexes. Chemical communications (Cambridge, England), (18), 2336-7. https://doi.org/10.1039/b306484k
Kuehl, Christopher J, et al. "Toward new paradigms in mixed-valency: ytterbocene-terpyridine charge-transfer complexes." Chemical communications (Cambridge, England) vol. ,18 (2003): 2336-7. doi: https://doi.org/10.1039/b306484k
Kuehl CJ, Da Re RE, Scott BL, Morris DE, John KD. Toward new paradigms in mixed-valency: ytterbocene-terpyridine charge-transfer complexes. Chem Commun (Camb). 2003 Sep 21;(18):2336-7. doi: 10.1039/b306484k. PMID: 14518902.
Copy Download .nbib Format: NLM
Occurrence, Parasitism, and Pathogenicity of Nematodes Associated with Sycamore (Platanus occidentalis L.).

Journal of nematology

Churchill RC, Ruehle JL.
PMID: 19322367
J Nematol. 1971 Apr;3(2):189-96.

Ten species of stylet-bearing nematodes were recovered in a survey of sycamore (Platanus occidentalis L. ) stands in Georgia. Helicotylenchus, Xiphinema, and Criconemoides were the genera found most frequently. Populations of Hoplolaimus galeatus, Scutellonema brachyurum, Helicotylenchus dihystera and H....

Cite
Churchill RC, Ruehle JL. Occurrence, Parasitism, and Pathogenicity of Nematodes Associated with Sycamore (Platanus occidentalis L.). J Nematol. 1971;3(2):189-96
Churchill, R. C., & Ruehle, J. L. (1971). Occurrence, Parasitism, and Pathogenicity of Nematodes Associated with Sycamore (Platanus occidentalis L.). Journal of nematology, 3(2), 189-96.
Churchill, R C, and Ruehle, J L. "Occurrence, Parasitism, and Pathogenicity of Nematodes Associated with Sycamore (Platanus occidentalis L.)." Journal of nematology vol. 3,2 (1971): 189-96.
Churchill RC, Ruehle JL. Occurrence, Parasitism, and Pathogenicity of Nematodes Associated with Sycamore (Platanus occidentalis L.). J Nematol. 1971 Apr;3(2):189-96. PMID: 19322367; PMCID: PMC2619866.
Copy Download .nbib Format: NLM
Worldwide data sets constrain the water vapor uptake coefficient in cloud formation.

Proceedings of the National Academy of Sciences of the United States of America

Raatikainen T, Nenes A, Seinfeld JH, Morales R, Moore RH, Lathem TL, Lance S, Padró LT, Lin JJ, Cerully KM, Bougiatioti A, Cozic J, Ruehl CR, Chuang PY, Anderson BE, Flagan RC, Jonsson H, Mihalopoulos N, Smith JN.
PMID: 23431189
Proc Natl Acad Sci U S A. 2013 Mar 05;110(10):3760-4. doi: 10.1073/pnas.1219591110. Epub 2013 Feb 19.

Cloud droplet formation depends on the condensation of water vapor on ambient aerosols, the rate of which is strongly affected by the kinetics of water uptake as expressed by the condensation (or mass accommodation) coefficient, αc. Estimates of αc...

Cite
Raatikainen T, Nenes A, Seinfeld JH, et al. Worldwide data sets constrain the water vapor uptake coefficient in cloud formation. Proc Natl Acad Sci U S A. 2013;110(10):3760-4doi: 10.1073/pnas.1219591110.
Raatikainen, T., Nenes, A., Seinfeld, J. H., Morales, R., Moore, R. H., Lathem, T. L., Lance, S., Padró, L. T., Lin, J. J., Cerully, K. M., Bougiatioti, A., Cozic, J., Ruehl, C. R., Chuang, P. Y., Anderson, B. E., Flagan, R. C., Jonsson, H., Mihalopoulos, N., & Smith, J. N. (2013). Worldwide data sets constrain the water vapor uptake coefficient in cloud formation. Proceedings of the National Academy of Sciences of the United States of America, 110(10), 3760-4. https://doi.org/10.1073/pnas.1219591110
Raatikainen, Tomi, et al. "Worldwide data sets constrain the water vapor uptake coefficient in cloud formation." Proceedings of the National Academy of Sciences of the United States of America vol. 110,10 (2013): 3760-4. doi: https://doi.org/10.1073/pnas.1219591110
Raatikainen T, Nenes A, Seinfeld JH, Morales R, Moore RH, Lathem TL, Lance S, Padró LT, Lin JJ, Cerully KM, Bougiatioti A, Cozic J, Ruehl CR, Chuang PY, Anderson BE, Flagan RC, Jonsson H, Mihalopoulos N, Smith JN. Worldwide data sets constrain the water vapor uptake coefficient in cloud formation. Proc Natl Acad Sci U S A. 2013 Mar 05;110(10):3760-4. doi: 10.1073/pnas.1219591110. Epub 2013 Feb 19. PMID: 23431189; PMCID: PMC3593859.
Copy Download .nbib Format: NLM
Neurotensin as a source of cyclic AMP and co-mitogen in fibrolamellar hepatocellular carcinoma.

Oncotarget

Riehle KJ, Kenerson HL, Riggle KM, Turnham R, Sullivan K, Bauer R, Scott JD, Yeung RS.
PMID: 31489118
Oncotarget. 2019 Aug 20;10(49):5092-5102. doi: 10.18632/oncotarget.27149. eCollection 2019 Aug 20.

Fibrolamellar hepatocellular carcinomas (FL-HCCs) possess a unique mutation that encodes a chimeric form of protein kinase A (DNAJ-PKAc), which includes a chaperonin binding domain. DNAJ-PKAc retains most of the biochemical properties of the native enzyme, however, and activity remains...

Cite
Riehle KJ, Kenerson HL, Riggle KM, et al. Neurotensin as a source of cyclic AMP and co-mitogen in fibrolamellar hepatocellular carcinoma. Oncotarget. 2019;10(49):5092-5102doi: 10.18632/oncotarget.27149.
Riehle, K. J., Kenerson, H. L., Riggle, K. M., Turnham, R., Sullivan, K., Bauer, R., Scott, J. D., & Yeung, R. S. (2019). Neurotensin as a source of cyclic AMP and co-mitogen in fibrolamellar hepatocellular carcinoma. Oncotarget, 10(49), 5092-5102. https://doi.org/10.18632/oncotarget.27149
Riehle, Kimberly J, et al. "Neurotensin as a source of cyclic AMP and co-mitogen in fibrolamellar hepatocellular carcinoma." Oncotarget vol. 10,49 (2019): 5092-5102. doi: https://doi.org/10.18632/oncotarget.27149
Riehle KJ, Kenerson HL, Riggle KM, Turnham R, Sullivan K, Bauer R, Scott JD, Yeung RS. Neurotensin as a source of cyclic AMP and co-mitogen in fibrolamellar hepatocellular carcinoma. Oncotarget. 2019 Aug 20;10(49):5092-5102. doi: 10.18632/oncotarget.27149. eCollection 2019 Aug 20. PMID: 31489118; PMCID: PMC6707953.
Copy Download .nbib Format: NLM
Design and Characterization of an "All-in-One" Lentiviral Vector System Combining Constitutive Anti-G.

Cancers

Zimmermann K, Kuehle J, Dragon AC, Galla M, Kloth C, Rudek LS, Sandalcioglu IE, Neyazi B, Moritz T, Meyer J, Rossig C, Altvater B, Eiz-Vesper B, Morgan MA, Abken H, Schambach A.
PMID: 32041222
Cancers (Basel). 2020 Feb 06;12(2). doi: 10.3390/cancers12020375.

Genetically modified T cells expressing chimeric antigen receptors (CARs) so far have mostly failed in the treatment of solid tumors owing to a number of limitations, including an immunosuppressive tumor microenvironment and insufficient CAR T cell activation and persistence....

Cite
Zimmermann K, Kuehle J, Dragon AC, et al. Design and Characterization of an "All-in-One" Lentiviral Vector System Combining Constitutive Anti-G. Cancers (Basel). 2020;12(2)doi: 10.3390/cancers12020375.
Zimmermann, K., Kuehle, J., Dragon, A. C., Galla, M., Kloth, C., Rudek, L. S., Sandalcioglu, I. E., Neyazi, B., Moritz, T., Meyer, J., Rossig, C., Altvater, B., Eiz-Vesper, B., Morgan, M. A., Abken, H., & Schambach, A. (2020). Design and Characterization of an "All-in-One" Lentiviral Vector System Combining Constitutive Anti-G. Cancers, 12(2), . https://doi.org/10.3390/cancers12020375
Zimmermann, Katharina, et al. "Design and Characterization of an "All-in-One" Lentiviral Vector System Combining Constitutive Anti-G." Cancers vol. 12,2 (2020). doi: https://doi.org/10.3390/cancers12020375
Zimmermann K, Kuehle J, Dragon AC, Galla M, Kloth C, Rudek LS, Sandalcioglu IE, Neyazi B, Moritz T, Meyer J, Rossig C, Altvater B, Eiz-Vesper B, Morgan MA, Abken H, Schambach A. Design and Characterization of an "All-in-One" Lentiviral Vector System Combining Constitutive Anti-G. Cancers (Basel). 2020 Feb 06;12(2). doi: 10.3390/cancers12020375. PMID: 32041222; PMCID: PMC7072617.
Copy Download .nbib Format: NLM
PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model.

Molecular therapy oncolytics

Alzubi J, Dettmer-Monaco V, Kuehle J, Thorausch N, Seidl M, Taromi S, Schamel W, Zeiser R, Abken H, Cathomen T, Wolf P.
PMID: 32728611
Mol Ther Oncolytics. 2020 Jun 24;18:226-235. doi: 10.1016/j.omto.2020.06.014. eCollection 2020 Sep 25.

While chimeric antigen receptor (CAR) T cell immunotherapy targeting CD19 has shown remarkable success in patients with lymphoid malignancies, the potency of CAR T cells in solid tumors is low so far. To improve the efficacy of CAR T...

Cite
Alzubi J, Dettmer-Monaco V, Kuehle J, et al. PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model. Mol Ther Oncolytics. 2020;18:226-235doi: 10.1016/j.omto.2020.06.014.
Alzubi, J., Dettmer-Monaco, V., Kuehle, J., Thorausch, N., Seidl, M., Taromi, S., Schamel, W., Zeiser, R., Abken, H., Cathomen, T., & Wolf, P. (2020). PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model. Molecular therapy oncolytics, 18226-235. https://doi.org/10.1016/j.omto.2020.06.014
Alzubi, Jamal, et al. "PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model." Molecular therapy oncolytics vol. 18 (2020): 226-235. doi: https://doi.org/10.1016/j.omto.2020.06.014
Alzubi J, Dettmer-Monaco V, Kuehle J, Thorausch N, Seidl M, Taromi S, Schamel W, Zeiser R, Abken H, Cathomen T, Wolf P. PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model. Mol Ther Oncolytics. 2020 Jun 24;18:226-235. doi: 10.1016/j.omto.2020.06.014. eCollection 2020 Sep 25. PMID: 32728611; PMCID: PMC7372156.
Copy Download .nbib Format: NLM
Autophosphorylation transforms DNA-PK from protecting to processing DNA ends.

Molecular cell

Liu L, Chen X, Li J, Wang H, Buehl CJ, Goff NJ, Meek K, Yang W, Gellert M.
PMID: 34936881
Mol Cell. 2022 Jan 06;82(1):177-189.e4. doi: 10.1016/j.molcel.2021.11.025. Epub 2021 Dec 21.

The DNA-dependent protein kinase (DNA-PK) initially protects broken DNA ends but then promotes their processing during non-homologous end joining (NHEJ). Before ligation by NHEJ, DNA hairpin ends generated during V(D)J recombination must be opened by the Artemis nuclease, together...

Cite
Liu L, Chen X, Li J, et al. Autophosphorylation transforms DNA-PK from protecting to processing DNA ends. Mol Cell. 2021;82(1):177-189.e4doi: 10.1016/j.molcel.2021.11.025.
Liu, L., Chen, X., Li, J., Wang, H., Buehl, C. J., Goff, N. J., Meek, K., Yang, W., & Gellert, M. (2022). Autophosphorylation transforms DNA-PK from protecting to processing DNA ends. Molecular cell, 82(1), 177-189.e4. https://doi.org/10.1016/j.molcel.2021.11.025
Liu, Lan, et al. "Autophosphorylation transforms DNA-PK from protecting to processing DNA ends." Molecular cell vol. 82,1 (2022): 177-189.e4. doi: https://doi.org/10.1016/j.molcel.2021.11.025
Liu L, Chen X, Li J, Wang H, Buehl CJ, Goff NJ, Meek K, Yang W, Gellert M. Autophosphorylation transforms DNA-PK from protecting to processing DNA ends. Mol Cell. 2022 Jan 06;82(1):177-189.e4. doi: 10.1016/j.molcel.2021.11.025. Epub 2021 Dec 21. PMID: 34936881.
Copy Download .nbib Format: NLM
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.

British journal of haematology

Lutfi F, Holtzman NG, Kansagra AJ, Mustafa Ali M, Bukhari A, Yan J, Samanta S, Gottlieb D, Kim DW, Matsumoto LR, Gahres N, Ruehle K, Lee ST, Law JY, Kocoglu MH, Atanackovic D, Yared JA, Hardy NM, Molitoris J, Mohindra P, Rapoport AP, Dahiya S.
PMID: 34500492
Br J Haematol. 2021 Nov;195(3):405-412. doi: 10.1111/bjh.17738. Epub 2021 Sep 09.

In the relapsed/refractory setting for treatment of large B-cell lymphoma (LBCL), chimeric antigen receptor T-cell (CAR-T) therapy has emerged as an effective treatment modality. Patients often have aggressive disease that requires prompt treatment in the form of bridging therapy...

Cite
Lutfi F, Holtzman NG, Kansagra AJ, et al. The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma. Br J Haematol. 2021;195(3):405-412doi: 10.1111/bjh.17738.
Lutfi, F., Holtzman, N. G., Kansagra, A. J., Mustafa Ali, M., Bukhari, A., Yan, J., Samanta, S., Gottlieb, D., Kim, D. W., Matsumoto, L. R., Gahres, N., Ruehle, K., Lee, S. T., Law, J. Y., Kocoglu, M. H., Atanackovic, D., Yared, J. A., Hardy, N. M., Molitoris, J., Mohindra, P., Rapoport, A. P., & Dahiya, S. (2021). The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma. British journal of haematology, 195(3), 405-412. https://doi.org/10.1111/bjh.17738
Lutfi, Forat, et al. "The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma." British journal of haematology vol. 195,3 (2021): 405-412. doi: https://doi.org/10.1111/bjh.17738
Lutfi F, Holtzman NG, Kansagra AJ, Mustafa Ali M, Bukhari A, Yan J, Samanta S, Gottlieb D, Kim DW, Matsumoto LR, Gahres N, Ruehle K, Lee ST, Law JY, Kocoglu MH, Atanackovic D, Yared JA, Hardy NM, Molitoris J, Mohindra P, Rapoport AP, Dahiya S. The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma. Br J Haematol. 2021 Nov;195(3):405-412. doi: 10.1111/bjh.17738. Epub 2021 Sep 09. PMID: 34500492.
Copy Download .nbib Format: NLM
Efficacy of Drug-Eluting Stents in Diabetic Patients Admitted with ST-Elevation Myocardial Infarctions Treated with Primary Percutaneous Coronary Intervention.

Journal of cardiovascular development and disease

Schmucker J, Fach A, Osteresch R, Mata Marin LA, Ruehle S, Retzlaff T, Garstka D, Eitel I, Hambrecht R, Wienbergen H.
PMID: 34436225
J Cardiovasc Dev Dis. 2021 Jul 21;8(8). doi: 10.3390/jcdd8080083.

BACKGROUND: Diabetic patients show higher adverse ischemic event rates and mortality when undergoing percutaneous coronary intervention (PCI) in acute myocardial infarctions. Therefore, diabetic patients might benefit even more from modern-generation drug-eluting stents (DES). The aim of the present study...

Cite
Schmucker J, Fach A, Osteresch R, et al. Efficacy of Drug-Eluting Stents in Diabetic Patients Admitted with ST-Elevation Myocardial Infarctions Treated with Primary Percutaneous Coronary Intervention. J Cardiovasc Dev Dis. 2021;8(8)doi: 10.3390/jcdd8080083.
Schmucker, J., Fach, A., Osteresch, R., Mata Marin, L. A., Ruehle, S., Retzlaff, T., Garstka, D., Eitel, I., Hambrecht, R., & Wienbergen, H. (2021). Efficacy of Drug-Eluting Stents in Diabetic Patients Admitted with ST-Elevation Myocardial Infarctions Treated with Primary Percutaneous Coronary Intervention. Journal of cardiovascular development and disease, 8(8), . https://doi.org/10.3390/jcdd8080083
Schmucker, Johannes, et al. "Efficacy of Drug-Eluting Stents in Diabetic Patients Admitted with ST-Elevation Myocardial Infarctions Treated with Primary Percutaneous Coronary Intervention." Journal of cardiovascular development and disease vol. 8,8 (2021). doi: https://doi.org/10.3390/jcdd8080083
Schmucker J, Fach A, Osteresch R, Mata Marin LA, Ruehle S, Retzlaff T, Garstka D, Eitel I, Hambrecht R, Wienbergen H. Efficacy of Drug-Eluting Stents in Diabetic Patients Admitted with ST-Elevation Myocardial Infarctions Treated with Primary Percutaneous Coronary Intervention. J Cardiovasc Dev Dis. 2021 Jul 21;8(8). doi: 10.3390/jcdd8080083. PMID: 34436225; PMCID: PMC8397182.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 75 entries